Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002-Reference-Cited by-同舟云学术

Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002

Published:2015-03-09 Issue:9 Volume:29 Page:1955-1958
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Karachunskiy A, ,Roumiantseva J,Lagoiko S,Bührer C,Tallen G,Aleinikova O,Bydanov O,Korepanova N,Bajdun L,Nasedkina T,von Stackelberg A,Novichkova G,Maschan A,Litvinov D,Myakova N,Ponomareva N,Kondratchik K,Fechina L,Streneva O,Judina N,Scharapova G,Shamardina A,Gerbek I,Shapochnik A,Rumjanzew A,Henze G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201563.pdf

Reference15 articles.

1. Karachunskiy A, Herold R, von Stackelberg A, Miakova N, Timakow A, Mahortih T et al. Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia 2008; 22: 1144–1153.

2. Jones B, Freeman AI, Shuster JJ, Jacquillat C, Weil M, Pochedly C et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol 1991; 19: 269–275.

3. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG . Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol 1987; 5: 202–207.

4. Stary J, Zimmermann M, Campbell M, Castillo L, Dibar E, Donska S et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the Randomized Intercontinental Trial ALL IC-BFM 2002. J Clin Oncol 2014; 32: 174–184.

5. Teuffel O, Kuster SP, Hunger SP, Conter V, Hitzler J, Ethier MC et al. Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia 2011; 25: 1232–1238.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia;Pediatric Hematology/Oncology and Immunopathology;2023-12-20

2. High-risk acute lymphoblastic leukemia in the ALL-MB 2002 study;Pediatric Hematology/Oncology and Immunopathology;2022-10-10

3. One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study;Journal of Cancer Research and Clinical Oncology;2022-09-28

4. Low-intensity therapy cures over 40 % of children with rapid Flow-MRD responding ALL: the ALL-MB 2008 trial results;Pediatric Hematology/Oncology and Immunopathology;2022-06-24

5. Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002;Journal of Cancer Research and Clinical Oncology;2019-03-06